Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Selegiline hydrochloride |
Is a |
False |
Selegiline (substance) |
Inferred relationship |
Some |
|
Product containing selegiline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline measurement |
Component |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline poisoning |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Accidental selegiline poisoning |
Causative agent (attribute) |
False |
Selegiline (substance) |
Inferred relationship |
Some |
|
Intentional selegiline poisoning |
Causative agent (attribute) |
False |
Selegiline (substance) |
Inferred relationship |
Some |
|
intoxication par la sélégiline d'intention indéterminée |
Causative agent (attribute) |
False |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline adverse reaction |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Allergy to selegiline (finding) |
Causative agent (attribute) |
False |
Selegiline (substance) |
Inferred relationship |
Some |
|
Selegiline overdose |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Accidental selegiline overdose |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Intentional selegiline overdose (disorder) |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
surdose de sélégiline d'intention indéterminée |
Causative agent (attribute) |
False |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Accidental selegiline poisoning |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Intentional selegiline poisoning |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline 6mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selegiline (substance) |
Inferred relationship |
Some |
|
Selegiline 9mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selegiline (substance) |
Inferred relationship |
Some |
|
Selegiline 12mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selegiline (substance) |
Inferred relationship |
Some |
|
Allergy to selegiline (finding) |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
|
Product containing selegiline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline-containing product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Product containing only selegiline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline 500 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline 500 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline 375 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline 375 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |
Selegiline only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Some |
1 |